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Abstract
Background: Laparoscopic adrenalectomy is considered the gold standard technique for the treatment of benign
small and medium size adrenal masses (<6 cm), due to low morbidity rate, short hospitalization and patient rapid
recovery. The aim of our study is to analyse the feasibility and efficiency of this surgical approach in a broad
spectrum of adrenal gland pathologies.
Methods: Pre-operative, intra-operative and post-operative data from 126 patients undergone laparoscopic adrenalectomy
between January 2003 and December 2015 were retrospectively collected and reviewed. Diagnosis was obtained on the
basis of clinical examination, laboratory values and imaging techniques. Doxazosin was preoperatively administered in case
of pheochromocytoma while spironolactone and potassium were employed to treat Conn’s disease. Laparoscopic
adrenalectomies were all performed by the same surgeon (CG). First 30 procedures were considered as learning curve
adrenalectomies.
Results: One hundred twenty-six patients were included in the study. Functioning tumors were diagnosed in 84 patients,
27 patients were affected by pheochromocytomas, 29 by Conn’s disease, 28 by Cushing disease. Surgery mean operative
time was 137.33 min (range 100–180) during the learning curve adrenalectomies and 96.5 min (range 75–110) in
subsequent procedures. Mean blood loss was respectively 160.2 ml (range 60–280) and 90.5 ml (range 50–200) in the
first 30 procedures and the subsequent ones. Only one conversion to open surgery occurred. No post-operative major
complications were observed, while minor complications occurred in 8 patients (0,79%). In 83 out of 84 functioning
neoplasms, laparoscopic adrenalectomy was effective in normalization of endocrine profile.
Conclusions: Laparoscopic adrenalectomy is a safe and feasible procedure, even for functioning masses and
pheochromocytomas. A multidisciplinary team including endocrinologists, endocrine surgeons and anaesthesiologists,
is recommended in the management of adrenal pathology, and adrenal surgery should be performed in referral high
volume centers. A thirty-procedures learning curve is recommended to improve surgical outcomes.
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Background
Nowadays different surgical approaches are available to
treat adrenal masses, any of them showing strengths and
weaknesses, and the choice of any approach depends on
different parameters (such as tumor size, malignancy,
patient’s conditions, surgical experience).
Large malignant adrenocortical tumors, due to haemo-
dynamic instability and the risk of tumor cell dissemin-
ation, are worldwide considered as indications to “open
surgery”, that is unavoidably associated to greater post-
operative pain and longer hospitalization causing higher
morbidity and mortality rate [1]. Laparoscopic adrenal-
ectomy (LA) by transabdominal lateral approach is con-
sidered a gold standard technique to treat a broad
spectrum of functioning and non-functioning adrenal
diseases, with described cases of resection of masses up
to 12–15 cm [2, 3]. Also robotic adrenalectomy and pos-
terior retroperitoneal adrenalectomy (PRA) [4] represent
excellent minimal invasive options, especially for benign
and medium sized (<6 cm) tumors. Low morbidity rate,
short hospitalization, improved cosmesis and a rapid re-
covery in addition to increasing patients satisfaction and
comfort are the main well known advantages [5].
Currently indication to LA for lesions >6 cm is still a
matter of debate and experienced endocrine surgeons
are divided between supporters [6–8] and detractors [9].
The Authors retrospectively reviewed data about 126
patients, undergone LA in endocrine academic referral
center, in order to evaluate safety and outcomes of
laparoscopic procedures in the treatment of adrenal
pathologies. Literature review was performed and col-




All clinical cases of patients undergone LA for adrenal
neoplasm between January 2003 and December 2015
were retrospectively reviewed. Diagnosis was obtained
on the basis of clinical examination, laboratory values
and imaging techniques (ultrasonography, computed
tomography and Magnetic Resonance Imaging) [10].
ASA score ≤ III, age less than 80 years old, adrenal be-
nign functioning tumors up to 8 cm in diameter, non-
functioning tumors ≤12 cm, and adrenal metastases
<6 cm were the main surgical inclusion criteria. Patients
with suspected primary malignant adrenal neoplasm, on
the basis of imaging examinations (local invasion or me-
tastases), were addressed to open surgery and not en-
rolled in the study [11]. Patients with definitive
pathology of primary malignant tumor were excluded
from the study. Patient’s evaluation included pre-
operative, intra-operative and post-operative data. Surgi-
cal procedures were all performed by the same surgeon
(CG), experienced in endocrine and laparoscopic sur-
gery, assisted by a collaborative team skilled in minimal
invasive surgery. The first 30 patients were considered
as part of the learning curve [12–14].
Pre-operative management
Before surgery, all patients underwent laboratory tests,
chest X-ray, ECG examination and cardiological counsel-
ing. A scheduled pharmacological treatment was admin-
istrated in case of pheocromocytomas (PCC) and Conn
syndrome. All patients were administered antithrom-
botic prophylaxis (heparin sodium 4000 U.I. s.c.). Pa-
tients diagnosed with PCC underwent an alpha-1
blocker – doxazosin 2 mg (3 cps per day), until blood
pressure (BP), heart rate (HR) and ECG stabilization
were achieved, (BP < 160/90 mmHg and HR < 100 beats
min for at least 24 h before surgery, ECG ST
normalization for at least 1 week before surgery). In case
of cardiological stabilization failure, a beta-blocker
(Atenolol 50 mg one cp per day) was administered as
well [15]. In each PCC case plasma volume was pre-
operatively expanded using crystalloid solutions.
Patients affected by Conn’s disease with low potassium
serum level, preoperatively were administered with spir-
onolactone 50 mg (1 to 6 cps per day) and Potassium
Aspartate 3 mEq/ml i.v. (one vial per day) in order to
reach normal range blood Potassium levels (n.r. 3,5–
5 mmol/l).
Intra-operative management
All patients received general anesthesia with orotracheal
intubation and antibiotic prophylaxis (cefazoline 2 g i.v.)
was performed. Anesthesia chart and pathology report
of each patient were collected. Systolic blood pressure
(SBP) levels ≥180 mmHg were considered hypertensive
crises, while SBP levels <90 mmHg were considered
hypotensive ones.
LA were performed using a standard transperitoneal
lateral laparoscopic approach. The patients were placed
in the left position (30° angle) for right LA, while they
were placed in right position (90° angle) for left LA.
Right LA was approached using 4 trocars, while left LA
was approached with 3 trocars. Pneumoperitoneum was
maintained at 12–14 mmHg by insufflation of carbon di-
oxide (CO2). Dissection was realized using Harmonic
scalpel™ (Ethicon Endo Surgery INC - Johnson &
Johnson, NJ, USA) or LigaSure ™ vessel sealing system
(Tyco, Boulder CO, USA). The first step consisted of
vascular control of the main adrenal vein by clips.
Whenever necessary, the lateral and posterior connec-
tions of the right hepatic lobe were incised and the liver
was superiorly and medially retracted, paying particular
attention in Cushing’s patients, in whom the liver may
be very fragile. For right adenomas larger than 6 cm,
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adrenal gland was mobilized on both the upper and
medial sides, in order to have a safer access to the infer-
ior cava vein and the ipsilateral renal vein. In left LA, a
wide left colon mobilization was routinely carried out.
The surgical specimens were extracted in retrieval bags
through a mini-laparotomy of the trocars. A 20 Fr drain-
age was routinely placed.
Post operative management
After surgery all patients were administered with fluids
(1000 ml of saline solution NaCl 0.9% + 1000 ml of poly-
saline solution +500 ml of glucose solution 5% i.v.) and
antithrombotic therapy (heparin sodium 4000 U.I. s.c.)
until discharge. Postoperative hypotensive crises were
treated by hydrocortisone and Crystalloids infusions i.v.
Early mobilization and feeding were recommended on
the first postoperative day. Drainage was removed on
the first or second post operative day. Major and minor
complications were recorded in patients’clinical folders.
Patients’ follow up consisted of clinical evaluation and
blood examination at the day 7–15-30 after discharge,
followed by half-yearly controls.
Statistics
Data were expressed as mean, unless otherwise specified.
Statistical analysis was performed with SPSS version 11.5
(SPSS©, Chicago, IL, USA). Significance was assigned
with a p value <0.05.
Results
From January 2003 until December 2015, 126 patients
(38 males, 88 females) were enrolled in the study. The
mean age was of 51.7 years old (range 22–76). Patients
comorbidities are reported in Table 1. A Right neoplasm
was present in 59% of the cases, while one patient pre-
sented bilateral masses. Functioning tumors were diag-
nosed in 84 patients (67%), 27 patients were affected by
PCC, 29 by Conn’s disease, 28 by Cushing. In 38 cases
diagnosis was incidental, while one patient was diag-
nosed as myelolipoma. Three patients presented adrenal
metastasis after being treated for breast and renal can-
cers respectively (Table 2). Mean size of adrenal
neoplasm was 5.75 cm (range 1.1 to 12 cm). According
to anaesthesiology counselling, 51 patients had ASA
score I, 56 had ASA II score, 19 patients were classified
ASA III. PCC patients well tolerated pre-operative ther-
apy with doxazosine, resulting in normalization of BP,
HR and ECG test after a mean time of 8.6 days (range 4
to 15 days). One patient needed beta-blocker supple-
mentary administration in order to reach pre-operative
goals. Five patients affected by Conn’s disease needed
supplementary Potassium administration in order to
reach normal range of potassium levels.
Regarding surgery, mean operative time was
137.33 min (range 100–180) during the learning curve
and 96.5 min (range 75–110) in subsequent procedures.
Mean blood loss was 160.2 ml (range 60–280) in first 30
procedures and it lowered to 90.5 ml (range 50–200) in
subsequent procedures (Table 3). No patient required
intra or postoperative blood transfusion. Both mean op-
erative time and mean blood loss resulted a statistically
significant difference between learning curve and total
operations (p < 0.05). Among intra-operative complica-
tions, it was reported one case of inferior vein cava in-
jury, sutured and treated by Floseal® Hemostatic Matrix
(Baxter Zurich Switzerland) and oxidized cellulose
(Tabotamp Fibrillar Johnson & Johnson, NJ, US), and
one case of diaphragm lesion due to pleural cavity open-
ing, both successfully treated without necessity of con-
version to open surgery. No cases of splenic or liver
injuries occurred in our series. It has been reported only
one case of conversion to open surgery (0.79%), due to
suspected infiltration of the renal vessels by a left PCC,
not confirmed at definitive pathology, which reported a
desmoplastic reaction.
Intraoperative hypertensive crises were reported in 16
cases (93% in PCC patients, 7% in Cushing patient), 3 at
the induction, 13 during adenoma manipulation (four
cases during the learning curve), while hypotensive cri-
ses were reported in 4 cases (one severe hypotension),
but they were promptly and successfully treated without
Table 1 Demographics
Percent
Mean age (years) 51.7
Male patients (n) 38 30.2
Female patients (n) 88 69.8
Cardiovascular disease (n) 35 27.8
Pulmonary disease (n) 20 25.2
ASA score 1–2 (n) 107 84.9
ASA score 3 (n) 19 15.1
Table 2 Adrenal neoplasms’ characteristics
Percent
Right site (n) 74 59
Left site (n) 51 40.2
Bilateral site (n) 1 0.79
Mean size (cm) 5.75 cm
PCC (n) 27 21.43
Conn’s (n) 29 23
Cushing (n) 28 22.22
Incidental (n) 38 30.16
Metastasis (n) 3 2.4
Myelolipoma (n) 1 0.79
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leading to post-operative injuries. Cardiac enzymes in-
creasing in absence of myocardial infarction clinical
manifestations was observed in one female PCC patient.
At definitive pathology, no occurrence of malignant
primary tumor was observed (0/126).
No postoperative mayor complication occurred. 30-
day morbidity rate was 6.3% (8/126 patients) with a sta-
tistically significant difference between learning curve
and subsequent operations, and consisted of three cases
of abdominal wall hematoma (two cases during the
learning curve), two cases of port site hernia (one case
during the learning curve), one case of pneumonia and
two intra-abdominal collection spontaneously resolved
(Table 3).
Mean hospitalization was 3.4 days (2–10 days). Mean
follow up was 47.78 months (6–160 months). Surgery
determined an hormonal serum levels normalization in
83 out of 84 diagnosed with functional adenoma
(98.8%); only one patient affected by PCC disease
showed a persistent postoperative hypertension and ele-
vation of metanephrine levels, due to retrocaval adrenal
tissue, requiring reoperation with posterior approach.
A male patient affected by Conn’s disease was diag-
nosed of a methacronous controlateral tumor about
8 years after a right LA, and was submitted to a sparing
ultrasound-assisted left LA. No complication and/or dis-
ease recurrence were observed at 54.43 month follow-up
(6–120 months),. Follow up in three female patients, af-
fected by breast and renal cancers, stated that they are
alive respectively 1, 2 and 4 years following LAs.
Discussion
Since the first successfully performed LA by Gagner in
1991 [16], the transperitoneal approach has become the
most common therapeutic strategy for adrenal neoplasm
[17]. Thanks to the minimal invasive approach, LA
allowed a decreased postoperative pain, a reduced ileus,
a shorter hospitalization, an earlier return to work and a
better cosmetic result, guarantying a lower morbidity (5
to 20%) and mortality rates (below 0,5%) [18–23]. OA,
associated to higher mortality (2–4%) and morbidity
rates (bleeding, pulmonary and cardiac issues, pulmon-
ary thromboembolism, wound infections), is worldwide
reserved only for large tumors (diameter > 6 cm) and
primary malignancies, based on the radicality of resec-
tion, minor tumor local recurrence, and major survival
[24–26]. Suspected primary malignant adrenal tumors
should be considered as contraindication to minimal in-
vasive approach, for the poor oncological outcome and
the high risk of peritoneal dissemination of primary ad-
renal cancer. Nevertheless, the best surgical approach is
still a matter of debate [27–30]. Several authors under-
line how family history, virilising features, mixed hormo-
nal secretion, rapid enhancement and rapid washout on
MRI contrast imaging are considered predictor factors
of malignancy, nevertheless only local invasion or metas-
tases are clear signs of adrenal cancer [11]. Basing on
these surgical principles, in our experience, thanks to a
careful and efficient anamnesis, together with laboratory
and imaging evaluation, no specimen was found malig-
nant at definitive pathology.
According to literature data [20, 31–33], LA is indi-
cated in patients affected by PCC up to 8 cm, incidenta-
lomas up to 6 cm and metastases <6 cm. Thanks to the
use of ultrasound or radiofrequency dissection, we also
demonstrated that minimal invasive approach can be
safely performed by experienced surgeons also in the
treatment of benign tumors larger than 6 cm and in case
of metastases, extending the previous surgical indica-
tions [5, 6, 34, 35]. Regarding devices efficacy, in our
series we did not observe significant differences between
Harmonic scalpel™ (Ethicon Endo Surgery INC -
Johnson & Johnson, NJ, USA) and LigaSure ™ vessel
sealing system (Tyco, Boulder CO, USA), nevertheless
we are more experienced with LigaSure ™. We retain in-
stead, as mandatory parameter, that LA should be
assessed by experienced laparoscopic surgeons after a
learning curve procedures [18, 36]. Basing on literature
data, we assumed the first 30 surgical procedures as
learning curve [12–14]. In our series, we observed a
Table 3 Peri-operative data
Learning Curve (30)b Subsequent Procedures (96)
Mean operative time (min) 137.33 (range 100–180) 96.5(range 75–110)*
Mean Intraoperative blood loss (ml) 160.2 (range 60–280) 90.5 (range 50–200)*(p < 0,01)
Hypertensive crises (SBP > 180 mmHg) 4/30 (13.3%) 12/96 (12.5%)
Hypotensive crises (SBP < 90 mmHg) 0/30 (0%) 4/96 (4.1%)
Conversion to open procedure (n) 1/30 (3.3%) 0/96 (0%)
30-day morbiditya (n) 3/30 (10%) 5/96 (5.2%)*(p = 0,025)
Mean Hospital stay (days) 4.5 (3–8 days) 3.4 (range 2–10 days)
Legend: (n) = number; (cm, ml, mmHg) =measurements; (min, days) = time
*statistically significant difference (p < 0,05)
aabdominal wall hematoma, pneumonia, port site hernia, intra-abdominal collection
b30 procedures were considered learning curve, basing on literature [12–14]
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significant reduction of mean operative time and intra-
operative blood loss comparing the first 30 procedures
to the subsequent ones. We referred these improve-
ments to a gained knowledge of anatomical connections,
leading to a safer manipulation of the inferior vein cava,
a prompter identification of the renal vein in order to
identify the medial adrenal vein (in left LA) and a more
efficient mobilization and retraction of the liver (in right
LA). Also post-operative complication rate resulted sig-
nificantly reduced, despite only subclinical sequelae oc-
curred even during the learning curve procedures.
Surgical approach was effective, safe and well toler-
ated, with a negligible morbidity rate. We reported only
one case of conversion to open surgery (0.79%), due to
suspected infiltration of the renal vessels by a left PCC,
not confirmed at definitive pathology, which reported a
desmoplastic reaction. In our series, a conversion to
open surgery, following intraoperative complications was
not necessary, and a “conservative” management of in-
ferior vena cava and diaphragm injuries were easily per-
formed, without excessive risks for the patients.
However, in case of intraoperative risky complications a
rapid conversion is mandatory to avoid life threatening
events [18].
A preoperative selective adrenergic blockade with dox-
azosin, routinely performed, did not prevent intraopera-
tive hypertensive episodes (16 cases), occurring
principally during tumor manipulation (13 out of 16
cases), and promptly treated by anaesthesiologists. Major
intraoperative cardiovascular complications - cerebral
vascular accident, pulmonary edema, myocardial infarc-
tion or ischemia, cardiac arrhythmias and multiorgan
failure - were not observed, although it is reported that
laparoscopic treatment for metastases or PCCs present
high risk for hemodynamic disorders [37]. Large indeter-
minate adrenal neoplasm, carcinoma, a tumor size
>6 cm and concomitant surgical procedures are consid-
ered the main risk factors predicting 30-day morbidity
[32]. In Cushing’s diseases, a higher post-operative infec-
tious complication rate was not observed.
The presented retrospective study has several limita-
tions. All operations were performed by a single team,
composed by experienced endocrine and laparoscopic
surgeons, in a tertiary referral center. The study design
was retrospective and a comparison with an “open sur-
gery” series was not carried out. Nevertheless it is pos-
sible to drawn some conclusions.
Conclusion
A multidisciplinary routinely management - endocrinol-
ogists, endocrine surgeons and anaesthesiologists - is
recommended in referral high volume units for the
treatment of adrenal pathology. An accurate pre-
operative examination is mandatory due to select eligible
patients to LA. LA is safe and feasible also for benign le-
sions up to 12 cm. A skilled operative team, composed
by endocrine surgeons experienced in LA after adequate
learning curve, is requested. Preoperative alfa-
blockade does not prevent PCC hypertensive crises
but, facilitating their pharmacological control, must
be recommended.
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